Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension

By sjmartinez • March 27, 2025

Channick R, Medrek S, Delcroix M, Gaine S, Jansa P, Lang I, McLaughlin V, Mehta S, Pulido T, Sastry B, Souza R, Torbicki A, Zhao C, Strachan P, Agron P, Yen J, Sitbon O. Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension. JHLT Open. 2025 Jan 16;7:100197. doi: 10.1016/j.jhlto.2024.100197. PMID: 40144855; PMCID: PMC11935431.

Tags: GRIPHON, Macitentan, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, Selexipag, SERAPHIN

The role of declining therapy volumes in skilled nursing facility outcomes: a mediation analysis

Prusynski RA, Humbert A, Amaravadi H, Burke RE, Saliba D, Leland NE, Freburger J, Mroz TM. The role of declining therapy volumes in skilled nursing[...]

Bloodstream Infections Among Veterans With Cardiac Implantable Electronic Devices: Source Identification and Intervention Strategies

Basnet D, Golenbock S, Strymish JM, Mull HJ, Lamkin RP, Shin M, Harvey K, Karchmer AW, Branch-Elliman W. Bloodstream Infections Among Veterans With Cardiac Implantable[...]

FRONTIER-3: a randomised phase 2a study to investigate tozorakimab, an anti-interleukin-33 monoclonal antibody, in early-onset asthma

Corren J, Reid F, Moate R, Jimenez E, Sadiq MW, Williams A, Rytelewski M, Cameron-Christie S, Muthas D, Georgi B, Brooks D, Lindqvist E, Kell[...]